ALX Oncology Holdings Inc. (ALXO) vs Korsana Biosciences, Inc. (KRSA)
A side-by-side comparison of ALX Oncology Holdings Inc. and Korsana Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.15HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
KRSA
Korsana Biosciences, Inc.
$31.12HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — ALXO vs KRSA
growth of $100 · dividends reinvested · last 6yALXO -96.0% (-41.4%/yr)KRSA -95.4% (-40.2%/yr)KRSA compounded faster over this window
ALXO KRSA
ALXO vs KRSA: by the numbers
- •ALXO is the larger company ($154M vs $146M market cap).
- •Both run net losses; ALXO's is the smaller (0.00% vs -353.00% net margin).
Metrics side by side
Valuation
| Metric | ALXO | KRSA |
|---|---|---|
| P/S ratio | N/A | 76.68 |
| P/B ratio | 1.13 | 28.64 |
Profitability
| Metric | ALXO | KRSA |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -239.78% |
| Net margin | 0.00% | -353.00% |
| ROE | -59.40% | -131.85% |
| ROIC | -56.53% | -134.15% |
Growth (annualized)
| Metric | ALXO | KRSA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -11.98% |
| Total return CAGR (5Y) | -56.07% | -40.41% |
Frequently asked
- How have ALXO and KRSA total returns compared?
- Over the past 5 years, ALXO delivered -56.07% and KRSA delivered -40.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.